axsome therapeutics Axsome Therapeutics (AXSM) Advances To Cross $100-Mark By www.rttnews.com Published On :: Mon, 27 Apr 2020 10:45:29 GMT Axsome Therapeutics Inc.'s (AXSM) phase II/III trial of investigational drug AXS-05 in Alzheimer's disease agitation has met the primary endpoint. Full Article
